PBS
May PBS update
A roundup of the latest changes to the PBS There have been a number of changes to the PBS from 1 May. Among the new items listed are four Norspan …
Apotex decision a warning bell
Apotex’ decision to pull two of its PBS-listed products should ring an alarm for the health and pharmaceuticals sector, says Belinda Wood, CEO of the Generic and Biosimilar Medicines Association. …
Pharmacy not getting credit it deserves: Quilty
Pharmacy is not getting the credit it deserves in creating savings through PBS reforms, Guild executive director David Quilty writes in this week’s edition of Forefront – and so it …
PBS cuts skyrocket
Latest PBS cuts just the beginning, Minister believes A “skyrocketing” number of medicines experiencing a reduction in their price in the April round of PBS cuts is only the beginning, …
Medicines sector reforms deliver consumer benefits and a sustainable PBS
Consumers, taxpayers and the national health system will benefit from the significant savings being delivered by medicine suppliers since 1 April, say Medicines Australia, the Generic and Biosimilar Medicines Association, …
Discount deal uptake high
Most pharmacies offering co-pay discount, Minister claims as first 6CPA trials are revealed More than three quarters of Australian pharmacies have offered the PBS co-pay discount, federal Minister for Health …
Patients must have the facts: Guild
Be honest about the true cost of the $1 discount, Guild urges pharmacists Australian pharmacists must be honest about the impact of the $1 PBS co-pay discount on their chances …
PBS sustainability proven, more cuts unnecessary: Medicines Partnership
The sustainability of the PBS has been highlighted by the release of Productivity Commission data which puts the cost of the PBS per person at a 10 year low, says …
Pharmacy back in the USSR under totalitarian Health Minister
The Government’s desire to control community pharmacy is starting to look dangerously Soviet, writes Peter Feros The Soviet era is long gone, but its spirit felt alive and well as …
Reconsider Panadol Osteo delisting in light of risks: Painaustralia
The PBS delisting of Panadol Osteo needs to be reconsidered in the light of cost and clinical safety implications, says Painaustralia. The organisation has highlighted the risk of adverse clinical …
Panadol Osteo, admit it was a mistake: Guild
It is time the government ‘fessed up’ that Panadol Osteo has been de-listed from the PBS by mistake, says the Guild today. It says that in April last year PBAC set very clear criteria …
Co-payment discount: DDS opts in
The co-payment of $1 discount is being offered by Discount Drug Stores (DDS), as it claims it will enable the group to offer better priced OTC meds and offset the PBS impact of …